|
Delayed
Japan Exchange
22:13:30 2026-09-03 EDT
|
5-day change | 1st Jan Change | ||
| 5,150.00 JPY | -0.58% |
|
-3.74% | -23.25% |
| Fiscal Period: March | 2017 (JPY) | 2018 (JPY) | 2019 (JPY) | 2020 (JPY) | 2021 (JPY) | 2022 (JPY) | 2023 (JPY) | 2024 (JPY) | 2025 (JPY) | 2026 (JPY) |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 4.94 | 4.74 | 4.77 | 4.59 | 4.67 | |||||
Return on Total Capital | 5.73 | 5.3 | 5.25 | 4.94 | 4.96 | |||||
Return On Equity % | 10.16 | 10.54 | 11.76 | 13.3 | 14.41 | |||||
Return on Common Equity | 10.16 | 10.54 | 11.76 | 13.3 | 14.41 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 22.85 | 22.69 | 25.35 | 25.13 | 25.17 | |||||
SG&A Margin | 9.86 | 9.06 | 8.72 | 7.29 | 7.01 | |||||
EBITDA Margin % | 12.06 | 12.38 | 15.17 | 15.94 | 16.38 | |||||
EBITA Margin % | 11.63 | 11.91 | 14.53 | 15.39 | 15.85 | |||||
EBIT Margin % | 11.61 | 11.86 | 14.49 | 15.35 | 15.82 | |||||
Income From Continuing Operations Margin % | 7.28 | 7.69 | 9.36 | 9.85 | 9.55 | |||||
Net Income Margin % | 7.28 | 7.69 | 9.36 | 9.85 | 9.55 | |||||
Net Avail. For Common Margin % | 7.28 | 7.69 | 9.36 | 9.85 | 9.55 | |||||
Normalized Net Income Margin | 7.18 | 7.33 | 8.83 | 9.07 | 8.76 | |||||
Levered Free Cash Flow Margin | -13.87 | -24.09 | -41.5 | -39.51 | -35.2 | |||||
Unlevered Free Cash Flow Margin | -13.63 | -23.79 | -41.1 | -38.86 | -33.94 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.68 | 0.64 | 0.53 | 0.48 | 0.47 | |||||
Fixed Assets Turnover | 11.66 | 10.72 | 9.16 | 10.3 | 13.13 | |||||
Receivables Turnover (Average Receivables) | 26.75 | 38.61 | 40.46 | 33.37 | 55.28 | |||||
Inventory Turnover (Average Inventory) | 0.85 | 0.75 | 0.53 | 0.46 | 0.43 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 3.94 | 3.17 | 4.23 | 4.42 | 4.84 | |||||
Quick Ratio | 1.15 | 0.71 | 0.52 | 0.7 | 0.36 | |||||
Operating Cash Flow to Current Liabilities | -0.35 | -0.33 | -0.87 | -0.73 | -0.75 | |||||
Days Sales Outstanding (Average Receivables) | 13.64 | 9.45 | 9.05 | 10.94 | 6.6 | |||||
Days Outstanding Inventory (Average Inventory) | 429.16 | 489.32 | 687.41 | 788.92 | 839.4 | |||||
Average Days Payable Outstanding | 47.6 | 27.1 | 24.88 | 19.88 | 14.14 | |||||
Cash Conversion Cycle (Average Days) | 395.21 | 471.67 | 671.57 | 779.98 | 831.86 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 80.12 | 102.27 | 129.54 | 191.77 | 209.44 | |||||
Total Debt / Total Capital | 44.48 | 50.56 | 56.43 | 65.73 | 67.68 | |||||
LT Debt/Equity | 56 | 57.99 | 96.51 | 141.78 | 163.4 | |||||
Long-Term Debt / Total Capital | 31.09 | 28.67 | 42.05 | 48.59 | 52.81 | |||||
Total Liabilities / Total Assets | 51.28 | 55.13 | 60.42 | 67.64 | 69.63 | |||||
EBIT / Interest Expense | 30.17 | 25.35 | 22.45 | 14.61 | 7.89 | |||||
EBITDA / Interest Expense | 31.35 | 26.46 | 23.51 | 15.16 | 8.17 | |||||
(EBITDA - Capex) / Interest Expense | 29.64 | 18.56 | 22.43 | 14.3 | 8.03 | |||||
Total Debt / EBITDA | 4.96 | 6.3 | 7.11 | 9.33 | 8.92 | |||||
Net Debt / EBITDA | 1.88 | 3.62 | 5.78 | 7.26 | 8.01 | |||||
Total Debt / (EBITDA - Capex) | 5.25 | 8.98 | 7.45 | 9.89 | 9.07 | |||||
Net Debt / (EBITDA - Capex) | 1.99 | 5.16 | 6.06 | 7.7 | 8.14 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 8.11 | 7.13 | 0.47 | 18.03 | 23.38 | |||||
Gross Profit, 1 Yr. Growth % | 16.94 | 6.37 | 12.24 | 16.99 | 23.61 | |||||
EBITDA, 1 Yr. Growth % | 23.53 | 9.99 | 23.06 | 24.01 | 26.81 | |||||
EBITA, 1 Yr. Growth % | 23.62 | 9.67 | 22.59 | 25 | 27.11 | |||||
EBIT, 1 Yr. Growth % | 23.38 | 9.48 | 22.68 | 25.08 | 27.18 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 20.46 | 13.25 | 22.3 | 24.1 | 19.73 | |||||
Net Income, 1 Yr. Growth % | 20.46 | 13.25 | 22.3 | 24.1 | 19.73 | |||||
Normalized Net Income, 1 Yr. Growth % | 22.47 | 9.26 | 21.1 | 21.17 | 19.25 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 20.47 | 13.25 | 22.3 | 24.1 | 19.73 | |||||
Accounts Receivable, 1 Yr. Growth % | 32.67 | -69.81 | 213.44 | -11.27 | -41.57 | |||||
Inventory, 1 Yr. Growth % | 17.03 | 26.98 | 42.94 | 31.56 | 30.91 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -3.18 | 36.93 | 3.35 | 6.64 | -12.46 | |||||
Total Assets, 1 Yr. Growth % | 9 | 18.85 | 24.35 | 34.37 | 18.27 | |||||
Tangible Book Value, 1 Yr. Growth % | 8.37 | 9.54 | 9.78 | 9.97 | 11.1 | |||||
Common Equity, 1 Yr. Growth % | 8.92 | 9.46 | 9.69 | 9.85 | 11.01 | |||||
Cash From Operations, 1 Yr. Growth % | 104K | 37.23 | 150.49 | 10.02 | 11.54 | |||||
Capital Expenditures, 1 Yr. Growth % | -36.94 | 502.86 | -81.14 | 53.5 | -63.51 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 839.75 | 86.01 | 73.09 | 12.39 | 9.9 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 941.72 | 86.99 | 73.52 | 11.6 | 7.77 | |||||
Dividend Per Share, 1 Yr. Growth % | 0 | 125 | 66.67 | 23.33 | 29.73 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 10.01 | 7.62 | 3.74 | 8.9 | 20.68 | |||||
Gross Profit, 2 Yr. CAGR % | 5.47 | 11.53 | 9.27 | 14.59 | 20.25 | |||||
EBITDA, 2 Yr. CAGR % | 5.18 | 16.57 | 16.34 | 23.53 | 25.4 | |||||
EBITA, 2 Yr. CAGR % | 4.48 | 16.44 | 15.95 | 23.79 | 26.05 | |||||
EBIT, 2 Yr. CAGR % | 4.38 | 16.22 | 15.89 | 23.87 | 26.12 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 3.47 | 16.8 | 17.69 | 23.2 | 21.9 | |||||
Net Income, 2 Yr. CAGR % | 3.47 | 16.8 | 17.69 | 23.2 | 21.9 | |||||
Normalized Net Income, 2 Yr. CAGR % | 3.53 | 15.68 | 15.03 | 21.14 | 20.21 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 3.47 | 16.8 | 17.69 | 23.2 | 21.9 | |||||
Accounts Receivable, 2 Yr. CAGR % | 79.77 | -36.71 | -2.73 | 66.77 | -28 | |||||
Inventory, 2 Yr. CAGR % | 17.97 | 21.9 | 34.73 | 37.13 | 31.24 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 13.15 | 15.14 | 18.96 | 4.98 | -3.38 | |||||
Total Assets, 2 Yr. CAGR % | 19.17 | 13.82 | 21.57 | 29.27 | 26.06 | |||||
Tangible Book Value, 2 Yr. CAGR % | 8.35 | 8.96 | 9.66 | 9.87 | 10.53 | |||||
Common Equity, 2 Yr. CAGR % | 8.63 | 9.19 | 9.57 | 9.77 | 10.43 | |||||
Cash From Operations, 2 Yr. CAGR % | -7.16 | 3.68K | 85.41 | 66.01 | 10.78 | |||||
Capital Expenditures, 2 Yr. CAGR % | -38.22 | 94.98 | 6.62 | -46.2 | -25.16 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -9.52 | 318.1 | 79.44 | 39.48 | 11.14 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -10.07 | 341.36 | 80.13 | 39.16 | 9.67 | |||||
Dividend Per Share, 2 Yr. CAGR % | 0 | 50 | 93.65 | 43.37 | 26.49 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 9.26 | 9.04 | 5.18 | 8.3 | 13.52 | |||||
Gross Profit, 3 Yr. CAGR % | 6.47 | 5.77 | 11.77 | 11.78 | 17.52 | |||||
EBITDA, 3 Yr. CAGR % | 7.14 | 6.76 | 18.69 | 18.84 | 24.62 | |||||
EBITA, 3 Yr. CAGR % | 6.57 | 6.18 | 18.45 | 18.89 | 24.89 | |||||
EBIT, 3 Yr. CAGR % | 6.5 | 6.05 | 18.34 | 18.88 | 24.96 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 6.66 | 6.63 | 18.61 | 19.79 | 22.03 | |||||
Net Income, 3 Yr. CAGR % | 6.66 | 6.63 | 18.61 | 19.79 | 22.03 | |||||
Normalized Net Income, 3 Yr. CAGR % | 5.82 | 5.41 | 17.46 | 17.04 | 20.5 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 6.66 | 6.63 | 18.61 | 19.79 | 22.03 | |||||
Accounts Receivable, 3 Yr. CAGR % | 66.25 | -0.82 | 7.87 | -5.66 | 17.57 | |||||
Inventory, 3 Yr. CAGR % | 25.77 | 20.9 | 28.55 | 33.66 | 35.03 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 13.77 | 20.58 | 11.07 | 14.7 | -1.19 | |||||
Total Assets, 3 Yr. CAGR % | 19.1 | 19.06 | 17.23 | 25.7 | 25.49 | |||||
Tangible Book Value, 3 Yr. CAGR % | 9.04 | 8.75 | 9.23 | 9.76 | 10.28 | |||||
Common Equity, 3 Yr. CAGR % | 9.24 | 8.91 | 9.36 | 9.67 | 10.18 | |||||
Cash From Operations, 3 Yr. CAGR % | 74.06 | 5.76 | 1.43K | 55.8 | 45.4 | |||||
Capital Expenditures, 3 Yr. CAGR % | 121.65 | 32.01 | -10.5 | 20.39 | -52.73 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 76.72 | 15.04 | 211.61 | 53.53 | 28.82 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 77.55 | 14.79 | 223.33 | 53.56 | 27.8 | |||||
Dividend Per Share, 3 Yr. CAGR % | 4.55 | 31.04 | 55.36 | 66.61 | 38.67 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 13.68 | 10.58 | 7.02 | 8.98 | 11.12 | |||||
Gross Profit, 5 Yr. CAGR % | 9.99 | 6.5 | 7.58 | 9.21 | 15.09 | |||||
EBITDA, 5 Yr. CAGR % | 11.26 | 7.49 | 10.73 | 13.18 | 21.33 | |||||
EBITA, 5 Yr. CAGR % | 11.08 | 7.1 | 10.23 | 12.9 | 21.44 | |||||
EBIT, 5 Yr. CAGR % | 11.03 | 7.02 | 10.16 | 12.85 | 21.39 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 11.79 | 7.38 | 10.94 | 12.97 | 19.91 | |||||
Net Income, 5 Yr. CAGR % | 11.79 | 7.38 | 10.94 | 12.97 | 19.91 | |||||
Normalized Net Income, 5 Yr. CAGR % | 11.15 | 6.92 | 9.41 | 11.44 | 18.55 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 11.79 | 7.38 | 10.94 | 12.97 | 19.91 | |||||
Accounts Receivable, 5 Yr. CAGR % | 62.93 | 15.06 | 34.17 | 22.1 | -8.23 | |||||
Inventory, 5 Yr. CAGR % | 23.31 | 25.2 | 29.28 | 27.15 | 29.62 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 6.71 | 14.07 | 15.82 | 14.08 | 5.05 | |||||
Total Assets, 5 Yr. CAGR % | 13.94 | 16.5 | 20.08 | 23.04 | 20.68 | |||||
Tangible Book Value, 5 Yr. CAGR % | 9.68 | 9.34 | 9.29 | 9.2 | 9.75 | |||||
Common Equity, 5 Yr. CAGR % | 9.8 | 9.44 | 9.37 | 9.25 | 9.78 | |||||
Cash From Operations, 5 Yr. CAGR % | 54.05 | 79.98 | 78.51 | 26.66 | 435.23 | |||||
Capital Expenditures, 5 Yr. CAGR % | 245.17 | 211.95 | 65.4 | -7.81 | -16.68 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 55.29 | 88.89 | 77.8 | 24.26 | 106.3 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 52.73 | 85.67 | 78.58 | 23.98 | 109.81 | |||||
Dividend Per Share, 5 Yr. CAGR % | 9.86 | 24.57 | 33.78 | 35.84 | 43.1 |
- Stock Market
- Stocks
- 8877 Stock
- Financials Eslead Corporation
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















